The Company - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended
	May 10, 2023	Nov. 30, 2021	Dec. 31, 2020	Jun. 30, 2023	Dec. 31, 2022	Jan. 01, 2021
Organization And Nature Of Business [Line Items]
Outstanding shares of redeemable convertible preferred stock						0
Accumulated deficit				$ 372,788	$ 314,490
Common Stock | Initial Public Offering
Organization And Nature Of Business [Line Items]
Number of shares sold and issued			9,660,000
Stock sold and issued price per share			$ 23.00
Aggregate net proceeds, after deducting underwriting discounts and commissions and offering costs			$ 204,700
Number shares issued upon conversion of redeemable convertible preferred shares			11,575,984
Common Stock | Excess of Overallotment Option
Organization And Nature Of Business [Line Items]
Number of shares sold and issued			1,260,000
Common Stock | 2021 Follow On Public Offering
Organization And Nature Of Business [Line Items]
Number of shares priced under public offering		4,750,000
Stock sold and issued price per share		$ 25.00
Aggregate net proceeds, after deducting underwriting discounts and commissions and offering costs		$ 111,100
Common Stock | 2023 Follow On Public Offering
Organization And Nature Of Business [Line Items]
Number of shares priced under public offering	8,625,000
Stock sold and issued price per share	$ 16.00
Aggregate net proceeds, after deducting underwriting discounts and commissions and offering costs	$ 129,200